General overview of the Sixth International Symposium on Stem Cell Therapy and Cardiovascular Innovations
Related Experiment Video
Updated: Jun 12, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
Published on: January 7, 2019
Ma Eugenia Vázquez-Alvarez1, Ricardo Sanz-Ruiz, Enrique Gutiérrez
1Cardiology Department, Hospital General Universitario Gregorio Marañón, Doctor Esquerdo 46, 28007 Madrid, Spain.
Insights
Advancements in stem cell therapy for cardiovascular innovation require standardization and larger clinical trials. Future directions include allogeneic stem cell products and bioartificial organs for regenerative medicine.
Area of Science:
- Cardiovascular Regenerative Medicine
- Stem Cell Therapy
Background:
- The Sixth International Symposium on Stem Cell Therapy and Cardiovascular Innovations convened experts in cardiovascular regenerative medicine.
- The symposium focused on discussing evidence and contributions from preclinical and clinical research in a translational manner.
Framework:
- The event aimed to foster collaboration between basic researchers, cardiologists, and cardiac surgeons.
- A special session and awards highlighted the contributions of young clinician scientists.
Implementation:
- Discussions emphasized the need for standardization in stem cell research.
- The importance of larger clinical trials and robust translational research was a key theme.
Implications:
- Future cardiovascular therapies may involve new allogeneic stem cell products.
- Biotechnological devices and cell-based bioartificial organs represent promising future options.
Abstract:
Being one of the main stem cell therapy meetings of the year, the Sixth International Symposium on Stem Cell Therapy and Cardiovascular Innovations was held on April 23rd-24th, 2009, at the Auditorium of the High Council of Scientific Research of Spain (CSIC) in Madrid. Gathering the most prestigious basic researchers and clinical experts in the field of cardiovascular regenerative medicine, the aim of the meeting was to discuss the available evidence and the recent contributions from preclinical investigators, cardiologists, and cardiac surgeons in a participative translational fashion. The role of young "clinician scientists" was reinforced with a special poster session and three awards. The main conclusions of the symposium were (1) that standardization, larger clinical trials, and true translational research are needed, and (2) that new-allogeneic-stem cell products, biotechnological devices, and cell-based bioartificial organs are potentially exciting options for the future.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Heart Failure VI: Adjunct Therapies
Stem Cell Culture
Clinical Applications of Epidermal Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Mesenchymal Stem Cells

